Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 7;18(11):2347-2354.
doi: 10.7150/ijms.57990. eCollection 2021.

The associations and roles of microRNA single-nucleotide polymorphisms in cervical cancer

Yaheng Li  1 , Chuanyin Li  1 , Shuyuan Liu  1 , Jia Yang  1 , Li Shi  1 , Yufeng Yao  1
Affiliations
Review

The associations and roles of microRNA single-nucleotide polymorphisms in cervical cancer

Yaheng Li et al. Int J Med Sci. .

Abstract

Cervical cancer is one of the fourth most common gynecological malignancies and has been identified as the fourth leading cause of cancer death in women worldwide. MicroRNAs (miRNAs) are single-stranded sequences of noncoding RNAs that are approximately 22-24 nucleotides in length. They modulate posttranscriptional mRNA expression and play critical roles in cervical cancer. Single nucleotide polymorphisms (SNPs) in miRNA genes may alter miRNA expression and maturation and have been associated with various cancers. This review mainly focuses on the roles of SNPs in miRNA genes in the development of cervical cancer and summarizes the research progress of miRNA SNPs in cervical cancer and their molecular regulation mechanisms.

Keywords: cervical cancer; miRNAs; regulation; single nucleotide polymorphisms.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interest exists.

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021. - PubMed
    1. Siegler E, Shiner M, Segev Y, Mackuli L, Lahat N, Lavie O. Prevalence and Genotype Distribution of HPV Types in Women at Risk for Cervical Neoplasia in Israel. The Israel Medical Association journal: IMAJ. 2017;19:635–9. - PubMed
    1. de Freitas AC, Gurgel AP, Chagas BS, Coimbra EC, do Amaral CM. Susceptibility to cervical cancer: an overview. Gynecologic oncology. 2012;126:304–11. - PubMed
    1. Sadri Nahand J, Moghoofei M, Salmaninejad A, Bahmanpour Z, Karimzadeh M, Nasiri M. et al. Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review. International journal of cancer. 2020;146:305–20. - PMC - PubMed
    1. Shen S, Zhang S, Liu P, Wang J, Du H. Potential role of microRNAs in the treatment and diagnosis of cervical cancer. Cancer genetics. 2020;248-249:25–30. - PubMed